The neuroprotective effects of purslane (Portulaca oleracea) on rotenone-induced biochemical changes and apoptosis in brain of rat

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 6, 2013, Pages 830-841

  Abdel Moneim, Ahmed E ^a  

^a HELWAN UNIVERSITY   (Egypt)

Author keywords

Dopamine; Neuroprotection; Purslane; Rat; Rotenone; Striatum

Indexed keywords

CALCIUM ION; DOPAMINE; FLAVONOID; NITRIC OXIDE; PHENOL; PORTULACA OLERACEA EXTRACT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; ROTENONE; TANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOASSAY; COLORIMETRY; CONTROLLED STUDY; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; MALE; MASS FRAGMENTOGRAPHY; NEUROPROTECTION; NONHUMAN; PORTULACA OLERACEA; RAT; SCANNING ELECTRON MICROSCOPY;

ANIMALS; APOPTOSIS; BRAIN; INSECTICIDES; MALE; NEUROPROTECTIVE AGENTS; PLANT EXTRACTS; PORTULACA; RATS; RATS, WISTAR; ROTENONE;

EID: 84888052712     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/18715273113129990081     Document Type: Article

References (53)

1. Viviani, P.; Burkhard, P.R.; Chiuve, S.C.; Corradi-Dell'Acqua, C.; Vindras, P. Velocity control in Parkinson's disease: a quantitative analysis of isochrony in scribbling movements. Exp. Brain Res., 2009, 194(2), 259-283.
2. Vaillancourt, D.E.; Spraker, M.B.; Prodoehl, J.; Abraham, I.; Corcos, D.M.; Zhou, X.J.; Comella, C.L.; Little, D.M. Highresolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology, 2009, 72(16), 1378-1384.
3. Haleagrahara, N.; Siew, C.J.; Mitra, N.K.; Kumari, M. Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum. Neurosci. Lett., 2011, 500(2), 139-143.
4. Lees, A.J. When did Ray Kennedy's Parkinson's disease begin? Mov. Disord., 1992, 7(2), 110-116.
5. Antkiewicz-Michaluk, L.; Karolewicz, B.; Romanska, I.; Michaluk, J.; Bojarski, A.J.; Vetulani, J. 1-methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain. Eur. J. Pharmacol., 2003, 466(3), 263-269.
6. Hu, L.F.; Lu, M.; Wu, Z.Y.; Wong, P.T.; Bian, J.S. Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function. Mol. Pharmacol., 2009, 75(1), 27-34.
7. István, U. Chapter 3-Pest Control Agents from Natural Products. In: Robert K (ed) Hayes' Handbook of Pesticide Toxicology (Third Edition). Academic Press, New York, 2010, 119-229.
8. Diaz-Corrales, F.J.; Asanuma, M.; Miyazaki, I.; Miyoshi, K.; Ogawa, N. Rotenone induces aggregation of gamma-tubulin protein and subsequent disorganization of the centrosome: relevance to formation of inclusion bodies and neurodegeneration. Neurosci., 2005, 133(1), 117-135.
9. Al-Quraishy, S.; Dkhil, M.A.; Abdel Moneim, A.E. Protective effects of Portulaca oleracea against rotenone mediated depletion of glutathione in the striatum of rats as an animal model of Parkinson's disease. Pestic. Biochem. Physiol., 2012, 103(2), 108-114.
10. Coulom, H.; Birman, S. Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster. J. Neurosci., 2004, 24(48), 10993-10998.
11. Bashkatova, V.; Alam, M.; Vanin, A.; Schmidt, W.J. Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain. Exp. Neurol., 2004, 186(2), 235-241.
12. Huang, Z.; Wang, B.; Eaves, D.H.; Shikany, J.M.; Pace, R.D. Phenolic compound profile of selected vegetables frequently consumed by African Americans in the southeast United States. Food Chem., 2007, 103(4), 1395-1402.
13. YouGuo, C.; ZongJi, S.; XiaoPing, C. Evaluation of free radicals scavenging and immunity-modulatory activities of Purslane polysaccharides. Int. J. Biol. Macromol., 2009, 45(5), 448-452.
14. Parry, O.; Marks, J.A.; Okwuasaba, F.K. The skeletal muscle relaxant action of Portulaca oleracea: role of potassium ions. J. Ethnopharmacol., 1993, 40(3), 187-194.
15. Chan, K.; Islam, M.W.; Kamil, M.; Radhakrishnan, R.; Zakaria, M.N.; Habibullah, M.; Attas, A. The analgesic and antiinflammatory effects of Portulaca oleracea L. subsp. Sativa (Haw.) Celak. J. Ethnopharmacol., 2000, 73(3), 445-451.
16. Oh, K.B.; Chang, I.M.; Hwang, K.J.; Mar, W. Detection of antifungal activity in Portulaca oleracea by a single-cell bioassay system. Phytother. Res., 2000, 14(5), 329-332.
17. Verma, O.P.; Kumar, S.; Chatterjee, S.N. Antifertility effects of common edible Portulaca oleracea on the reproductive organs of male albino mice. Indian J. Med. Res., 1982, 75, 301-310.
18. Gong, F.; Li, F.; Zhang, L.; Li, J.; Zhang, Z.; Wang, G. Hypoglycemic effects of crude polysaccharide from purslane. Int. J. Mol. Sci., 2009, 10(3), 880-888.
19. Rashed, A.N.; Afifi, F.U.; Disi, A.M. Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1. J. Ethnopharmacol., 2003, 88(2-3), 131-136.
20. Abdel Moneim, A.E.; Dkhil, M.A.; Al-Quraishy, S. The potential role of Portulaca oleracea as a neuroprotective agent in rotenoneinduced neurotoxicity and apoptosis in the brain of rats. Pestic. Biochem. Physiol., 2013, 105(3), 203-212.
21. Kim, D.O.; Chun, O.K.; Kim, Y.J.; Moon, H.Y.; Lee, C.Y. Quantification of polyphenolics and their antioxidant capacity in fresh plums. J. Agric. Food Chem., 2003, 51(22), 6509-6515.
22. Dewanto, V.; Wu, X.; Liu, R.H. Processed sweet corn has higher antioxidant activity. J. Agric. Food Chem., 2002, 50(17), 4959-4964.
23. Oyaizu, M. Studies on products of browning reaction: antioxidative activities of products of browning reaction prepared from glucosamine. Japanese J. Nutr., 1986, 44, 307-315.
24. Burits, M.; Bucar, F. Antioxidant activity of Nigella sativa essential oil. Phytother. Res., 2000, 14(5), 323-328.
25. Singh, R.; Singh, S.; Kumar, S.; Arora, S. Evaluation of antioxidant potential of ethyl acetate extract/fractions of Acacia auriculiformis A. Cunn. Food. Chem. Toxicol., 2007, 45(7), 1216-1223.
26. Dkhil, M.A.; Abdel Moneim, A.E.; Al-Quraishy. S.; Saleh, R.A. Antioxidant Effect of Purslane (Portulaca oleracea) and its Mechanism of Action. J. Med. Plant Research., 2011, 5, 1589-1593.
27. Glowinski, J.; Axelrod, J.; Iversen, L.L. Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. J. Pharmacol. Exp. Ther., 1966, 153(1), 30-41.
28. Jones, D.T.; Hopkin, S.P. Reduced survival and body size in the terrestrial isopod Porcellio scaber from a metal-polluted environment. Environ. Pollut., 1998, 99(2), 215-223.
29. Gibb, R.K.; Taylor, D.D.; Wan, T.; O'Connor, D.M.; Doering, D.L.; Gercel-Taylor, C. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines. Gynecol. Oncol., 1997, 65(1), 13-22.
30. Burton, K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J., 1956, 62(2), 315-323.
31. Shen, Y.; White, E. p53-Dependent apoptosis pathways. In: Advances in Cancer Research. Academic Press, 2001, 82, 55-84.
32. Dumont, M.; Beal, M.F. Neuroprotective strategies involving ROS in Alzheimer disease. Free Radic. Biol. Med., 2011, 51(5), 1014-1026.
33. Jimenez-Del-Rio, M.; Guzman-Martinez, C.; Velez-Pardo, C. The effects of polyphenols on survival and locomotor activity in Drosophila melanogaster exposed to iron and paraquat. Neurochem. Res., 2010, 35(2), 227-238.
34. Girish, C.M. Propensity of Selaginella delicatula aqueous extract to offset rotenone-induced oxidative dysfunctions and neurotoxicity in Drosophila melanogaster: Implications for Parkinson's disease. Neurotoxicol., 2012, 33(3), 444-456.
35. Elbaz, A.; Tranchant, C. Epidemiologic studies of environmental exposures in Parkinson's disease. J. Neurol. Sci., 2007, 262(1-2), 37-44.
36. Miller, R.L.; James-Kracke, M.; Sun, G.Y.; Sun, A.Y. Oxidative and inflammatory pathways in Parkinson's disease. Neurochem. Res., 2009, 34(1), 55-65.
37. Sherer, T.B.; Richardson, J.R.; Testa, C.M.; Seo, B.B.; Panov, A.V.; Yagi, T.; Matsuno-Yagi, A.; Miller, G.W.; Greenamyre, J.T. Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease. J. Neurochem., 2007, 100(6), 1469-1479.
38. Antkiewicz-Michaluk, L.; Michaluk, J.; Mokrosz, M.; Romanska, I.; Lorenc-Koci, E.; Ohta, S.; Vetulani, J. Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties. J. Neurochem., 2001, 78(1), 100-108.
39. Perier, C.; Vila, M. Mitochondrial biology and Parkinson's disease. Cold Spring Harb. Perspect. Med., 2012, 2(2), a009332.
40. Vaccari, A.; Saba, P. The tyramine-labelled vesicular transporter for dopamine: a putative target of pesticides and neurotoxins. Eur. J. Pharmacol., 1995, 292(3-4), 309-314.
41. Betarbet, R.; Sherer, T.B.; MacKenzie, G.; Garcia-Osuna, M.; Panov, A.V.; Greenamyre, J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 2000, 3(12), 1301-1306.
42. Havsteen, B.H. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther., 2002, 96(2-3), 67-202.
43. Molina-Jimenez, M.F.; Sanchez-Reus, M.I.; Andres, D.; Cascales, M.; Benedi, J. Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells. Brain Res., 2004, 1009(1-2), 9-16.
44. 2+ signaling in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurosci. Lett., 2005, 376(2), 127-132.
45. Nicotera, P.; Orrenius, S. The role of calcium in apoptosis. Cell Calcium, 1998, 23(2-3), 173-180.
46. Nègre-Salvayre, A.; Salvayre, R. UV-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. 4. Calcium is involved in the cytotoxicity of UV-treated LDL on lymphoid cell lines. Biochim. Biophys. Acta, Lipids Lipid Metab., 1992, 1123(2), 207-215.
47. Zimmer, L,; Delion-Vancassel, S.; Durand, G.; Guilloteau, D.; Bodard, S.; Besnard, J.C.; Chalon, S. Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J. Lipid Res., 2000, 41(1):32-40.
48. Bowen, R.A.; Clandinin, M.T. Dietary low linolenic acid compared with docosahexaenoic acid alter synaptic plasma membrane phospholipid fatty acid composition and sodium-potassium ATPase kinetics in developing rats. J. Neurochem., 2002, 83(4), 764-774.
49. Sinclair, A.J., Begg, D.; Mathai, M.; Weisinger, R.S. Omega 3 fatty acids and the brain: review of studies in depression. Asia Pac. J. Clin. Nutr., 2007, 16 Suppl 1, 391-397.
50. Hamilton, L.; Greiner, R.; Salem, N.; Jr., Kim, H.Y. n-3 fatty acid deficiency decreases phosphatidylserine accumulation selectively in neuronal tissues. Lipids, 2000, 35(8), 863-869.
51. Logan, A.C. Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern. Med. Rev., 2003, 8(4), 410-425.
52. Chalon, S.; Delion-Vancassel, S.; Belzung, C.; Guilloteau, D.; Leguisquet, A.M.; Besnard, J.C.; Durand, G. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J. Nutr., 1998, 128(12), 2512-2519.
53. Aldini, G.; Carini, M.; Piccoli, A.; Rossoni, G.; Facino, R.M. Procyanidins from grape seeds protect endothelial cells from peroxynitrite damage and enhance endothelium-dependent relaxation in human artery: new evidences for cardio-protection. Life Sci., 2003, 73(22), 2883-2898.